Staphylococcus epidermidis DSM 20042 is a human pathogen that was isolated from tropical superficial axillary dermatitis.
human pathogen Bacteria| @ref 20215 |
Last LPSN update
2026-05-29 08:28:18 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus epidermidis |
| Full scientific name Staphylococcus epidermidis (Winslow and Winslow 1908) Evans 1916 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 8448 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive  | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water | ||
| 34995 | MEDIUM 3 - Columbia agar | Columbia agar (39.000 g);distilled water (1000.000 ml) | |||
| 8448 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base |
| Test 1 | |
|---|---|
| @ref | 8448 |
| Medium | Mueller-Hinton Agar |
| Manual annotation | 1 |
| Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 30 |
| Ampicillin 10µg (disc) | 46 |
| Aztreonam 30µg (disc) | 0 |
| Bacitracin 10Unit | 18 |
| Cefalotin 30µg (disc) | 48 |
| Cefazolin 30µg (disc) | 42-44 |
| Cefotaxime 30µg (disc) | 36 |
| Ceftriaxone 30µg (disc) | n.d. |
| Chloramphenicol 30µg (disc) | 36 |
| Clindamycin 10µg (disc) | n.d. |
| Colistin 10µg (disc) | 10 |
| Doxycycline 30µg (disc) | 10-12 |
| Erythromycin 15µg (disc) | 34-36 |
| Fosfomycin 50µg (disc) | n.d. |
| Gentamicin 10µg (disc) | 30-32 |
| Imipenem 10µg (disc) | >50 |
| Kanamycin 30µg (disc) | 30-32 |
| Lincomycin 15µg (disc) | 34 |
| Linezolid 10µg (disc) | n.d. |
| Mezlocillin 30µg (disc) | 42 |
| Moxifloxacin 5µg (disc) | n.d. |
| Neomycin 30µg (disc) | 26-28 |
| Nitrofurantoin 100µg (disc) | 30 |
| Norfloxacin 10µg (disc) | 34-36 |
| Nystatin 100Unit | n.d. |
| Ofloxacin 5µg (disc) | 32 |
| Oxacillin 5µg (disc) | 40 |
| Penicillin G 6µg (disc) | 50 |
| Pipemidic acid 20µg (disc) | 20-22 |
| Piperacillin/Tazobactam 40µg (disc) | n.d. |
| Polymyxin B 300Unit | 12-14 |
| Quinupristin/Dalfopristin 15µg (disc) | n.d. |
| Teicoplanin 30µg (disc) | n.d. |
| Tetracycline 30µg (disc) | 0 |
| Ticarcillin 75µg (disc) | >50 |
| Vancomycin 30µg (disc) | 22 |
| @ref | Murein short key | Type | |
|---|---|---|---|
| 8448 | A11.03 | A3alpha L-Lys-Gly2-4-L-Ser1-2-Gly |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68375 | 22599 ChEBI | arabinose | - | fermentation | from API ID32STA |
| 68375 | 29016 ChEBI | arginine | + | hydrolysis | from API ID32STA |
| 68375 | 17057 ChEBI | cellobiose | - | fermentation | from API ID32STA |
| 68375 | 15824 ChEBI | D-fructose | + | fermentation | from API ID32STA |
| 68375 | 17634 ChEBI | D-glucose | + | fermentation | from API ID32STA |
| 68375 | 16899 ChEBI | D-mannitol | - | fermentation | from API ID32STA |
| 68375 | 16988 ChEBI | D-ribose | - | fermentation | from API ID32STA |
| 68375 | 4853 ChEBI | esculin | - | hydrolysis | from API ID32STA |
| 68375 | 17716 ChEBI | lactose | - | fermentation | from API ID32STA |
| 68375 | 17306 ChEBI | maltose | + | fermentation | from API ID32STA |
| 68375 | 59640 ChEBI | N-acetylglucosamine | - | fermentation | from API ID32STA |
| 68375 | 17632 ChEBI | nitrate | + | reduction | from API ID32STA |
| 68375 | 18257 ChEBI | ornithine | - | degradation | from API ID32STA |
| 68375 | 16634 ChEBI | raffinose | - | fermentation | from API ID32STA |
| 68375 | 17992 ChEBI | sucrose | + | fermentation | from API ID32STA |
| 68375 | 27082 ChEBI | trehalose | - | fermentation | from API ID32STA |
| 68375 | 32528 ChEBI | turanose | + | fermentation | from API ID32STA |
| 68375 | 16199 ChEBI | urea | + | hydrolysis | from API ID32STA |
| @ref | ChEBI | Group ID | Metabolite | Is sensitive | Sensitivity conc. | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|---|---|---|
| 8448 | 161680 | Aztreonam | 30 µg (disc) | from Antibiotic test | ||||
| 68375 | 28368 | 0 | novobiocin | 1.8 µg | from API ID32STA | |||
| 8448 | 27902 | Tetracycline | 30 µg (disc) | from Antibiotic test |
| @ref | Chebi-ID | Metabolite | Production | |
|---|---|---|---|---|
| 68375 | 15688 ChEBI | acetoin | from API ID32STA |
| @ref | Chebi-ID | Metabolite | Voges-proskauer-test | |
|---|---|---|---|---|
| 68375 | 15688 ChEBI | acetoin | + | from API ID32STA |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68375 | alkaline phosphatase | + | 3.1.3.1 | from API ID32STA |
| 68375 | arginine dihydrolase | + | 3.5.3.6 | from API ID32STA |
| 68375 | beta-galactosidase | - | 3.2.1.23 | from API ID32STA |
| 68375 | beta-glucosidase | - | 3.2.1.21 | from API ID32STA |
| 68375 | beta-glucuronidase | - | 3.2.1.31 | from API ID32STA |
| 68375 | L-arginine arylamidase | - | from API ID32STA | |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 | from API ID32STA |
| 68375 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API ID32STA |
| 68375 | urease | + | 3.5.1.5 | from API ID32STA |
| @ref | URE | ADH (Arg) | ODC | ESC | GLU | FRU | MNE | MAL | LAC | TRE | MAN | RAF | RIB | CEL | Reduction of nitrateNIT | Acetoin production (Voges Proskauer test)VP | beta GAL | L-arginine arylamidaseArgA | PAL | Pyrrolidonyl arylamidasePyrA | NOVO | SAC | NAG | TUR | ARA | beta GUR | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8448 | + | + | - | - | + | + | + | + | - | - | - | - | - | - | + | + | - | - | + | - | - | + | - | + | - | - | |
| 8448 | + | + | - | - | + | + | - | + | - | - | - | - | - | - | + | + | - | - | + | - | - | + | - | + | - | - | |
| 8448 | + | + | - | - | + | + | + | + | - | - | - | - | - | - | + | + | - | - | + | - | - | + | - | + | - | - |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Phylogeny | Genotypic and Phenotypic Characterization of Fecal Staphylococcus epidermidis Isolates Suggests Plasticity to Adapt to Different Human Body Sites. | Garcia-Gutierrez E, Walsh CJ, Sayavedra L, Diaz-Calvo T, Thapa D, Ruas-Madiedo P, Mayer MJ, Cotter PD, Narbad A. | Front Microbiol | 10.3389/fmicb.2020.00688 | 2020 | |
| Enzymology | Curvularia haloperoxidase: antimicrobial activity and potential application as a surface disinfectant. | Hansen EH, Albertsen L, Schafer T, Johansen C, Frisvad JC, Molin S, Gram L. | Appl Environ Microbiol | 10.1128/aem.69.8.4611-4617.2003 | 2003 | |
| Enzymatic removal and disinfection of bacterial biofilms. | Johansen C, Falholt P, Gram L. | Appl Environ Microbiol | 10.1128/aem.63.9.3724-3728.1997 | 1997 | | |
| Enzymology | Teichoicase from Bacillus subtilis Marburg. | Kusser W, Fiedler F. | J Bacteriol | 10.1128/jb.155.1.302-310.1983 | 1983 | |
| Chitosan nanoparticles-encapsulated cannabis extracts and their antimicrobial potential against skin pathogens. | Skala T, Ventura J, Morella-Aucejo A, Frankova A, Llopis-Lorente A, Bernardos A, Tauchen J, Kahankova Z, Hubka V, Kloucek P. | Front Med (Lausanne) | 10.3389/fmed.2025.1644502 | 2025 | | |
| Medical cannabis dimethyl ether, ethanol and butane extracts inhibit the in vitro growth of bacteria and dermatophytes causing common skin diseases. | Skala T, Kahankova Z, Tauchen J, Janatova A, KlouVcek P, Hubka V, FraVnkova A. | Front Microbiol | 10.3389/fmicb.2022.953092 | 2022 | | |
| Pathogenicity | Staphylococcus epidermidis Phages Transduce Antimicrobial Resistance Plasmids and Mobilize Chromosomal Islands. | Fisarova L, Botka T, Du X, Maslanova I, Bardy P, Pantucek R, Benesik M, Roudnicky P, Winstel V, Larsen J, Rosenstein R, Peschel A, Doskar J. | mSphere | 10.1128/msphere.00223-21 | 2021 | |
| Phylogeny | Simplified lyogroup system, a new method for routine identification of staphylococci: description and comparison with three other methods. | Varaldo PE, Grazi G, Soro O, Cisani G, Satta G. | J Clin Microbiol | 10.1128/jcm.12.1.63-68.1980 | 1980 | |
| Pathogenicity | Infection risk associated with a closed luer access device. | Adams D, Karpanen T, Worthington T, Lambert P, Elliott TS | J Hosp Infect | 10.1016/j.jhin.2005.09.016 | 2006 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive14528.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License